Search the Newsreel

Aspen Aerogels Inc (ASPN) (Q2 2026) Earnings Call Highlights: Strong Q3 Outlook and European ...

Aspen Aerogels Inc (ASPN) reported Q2 2026 revenue of $49.8 million, a 32% increase quarter-over-quarter, and provided a strong Q3 2026 revenue outlook of $65 million to $80 million. The company raised its 2026 European Thermal Barrier revenue outlook due to a new Jaguar …

Aspen Aerogels, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:ASPN) 2026-08-07

Jasper Therapeutics (NASDAQ:JSPR): Why Is the Stock Back in Focus as the Latest Update Arrives?

ASP Isotopes (ASPI) Projected to Announce Quarterly Earnings on Friday

ASP Isotopes (ASPI) is projected to announce its Q2 2026 earnings on Friday, August 14th, with analysts forecasting a loss of $0.17 per share and revenue of $4.47 million. The company reported a smaller loss and higher revenue than expected in the previous quarter. …

Form 8K ASP Isotopes Inc For: 6 August By Investing.com

This article is a brief financial market announcement from Investing.com, stating that ASP Isotopes Inc. filed a Form 8K on August 6. It provides no further details about the filing itself, serving primarily as a news headline. The article also lists various market data …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Jasper Therap

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jasper Therapeutics, Inc. (NASDAQ:JSPR) securities. The investigation focuses on whether Jasper and its officers engaged in corporate wrongdoing, particularly for investors who purchased shares before November 30, 2023, and continue …

Aspen Pharmacare Stock Stands Out As South Africa Tariff Exemptions Reshape Trade Picks

Press Release: Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Aspen Aerogels, Inc. reported its second quarter 2026 financial results, including revenue growth and significant advancements in its electric vehicle (EV) thermal barrier business. The company highlighted increased market penetration with its PyroThin® products and updated its full-year 2026 financial outlook, anticipating continued strong …

Aspen Aerogels (NYSE:ASPN) Shares Gap Up After Better-Than-Expected Earnings

Earnings call transcript: Aspen Aerogels Q2 2026 revenue beat lifts shares

Key Points Interested in Aspen Aerogels, Inc.? Here are five stocks we like better. Aspen Aerogels expects a sharp third-quarter rebound, forecasting revenue of $65 million–$80 million and adjusted EBITDA of $7 million–$15 million, driven by energy-industrial deliveries, higher GM EV production and stronger …

Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates

Aspen Aerogels (ASPN) reported a Q2 loss of $0.22 per share, meeting the Zacks Consensus Estimate, and revenues of $49.85 million, surpassing estimates by 17.84%. While the company has outperformed the market year-to-date, its current Zacks Rank of #3 (Hold) suggests it is expected …

ASP Isotopes to Participate in Citi’s 2026 Natural Resources Conference

ASP Isotopes Inc. (NASDAQ: ASPI) announced its participation in Citi's 2026 Natural Resources Conference in Las Vegas, Nevada, on Thursday, August 13, 2026, where it will host investor meetings. The company, an advanced materials firm, focuses on developing isotope enrichment technologies for critical materials …

Form 8K Aspen Aerogels Inc For: 6 August By Investing.com

This article announces that Aspen Aerogels Inc. has filed a Form 8K on August 6. It includes a brief mention of the company's stock symbol ASPN and its current performance. The content primarily consists of financial market data and unrelated news headlines.

Caspin Resources (ASX:CPN) Gains as Kelpie Tin Resource Sets a New Baseline

Aspen Aerogels: Q2 Earnings Snapshot

Aspen Aerogels (NYSE:ASPN) Updates Q3 2026 Earnings Guidance

Aspen Aerogels (ASPN) Earnings Date and Reports 2026

Jasper Therapeutics Inc (JSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Aspinwall & Company reports consolidated net loss of Rs 0.70 crore in the June 2026 quarter

ASP Isotopes to host investor meetings at Citi Natural Resources Conference Aug. 13

ASP Isotopes (ASPI) will host investor meetings at Citi's 2026 Natural Resources Conference in Las Vegas on August 13, 2026. The company's latest investor presentation is available on its website, and a press release mentions proposed merger transactions involving ENDRA, Renergen, and Noble Africa. …

Jasper Therapeutics, Inc. announced that it has received $131.999613 million in funding from a group of investors

Jasper Therapeutics, Inc. announced that it has successfully raised $131.999613 million in funding from a group of 40 investors. The company closed this transaction on August 5, 2026, by issuing 4,656,071 non-voting convertible preferred shares at an issue price of $28.35 per preferred share. …

Aspen Group (ASX:APZ) Edges Lower While Rental and Development Earnings Expand

ACES trails MDIY on margins despite similar revenue

Aspen Aerogels, Inc. to Present at the 29th Annual Oppenheimer Conference

Aspen Aerogels, Inc. (NYSE: ASPN) announced its participation in the 29th Annual Oppenheimer Technology, Internet & Communications Conference. President & CEO Don Young and CFO & Treasurer Grant Thoele will host one-on-one meetings and deliver a virtual presentation on August 11, 2026, accessible via …

Aspen Aerogels to present at Oppenheimer Conference on Aug 11, highlighting sustainability tech.

Aspen Aerogels will virtually present at the 29th Annual Oppenheimer Technology, Internet & Communications Conference on August 11, 2026. The company's CEO and CFO will engage with investors and discuss their aerogel technology, known for its applications in energy efficiency and electric vehicle safety. …

Jasper Therapeutics (JSPR) completes $131.9M Rule 506(b) private equity sale

Jasper Therapeutics (JSPR) has successfully completed a private exempt equity offering under Rule 506(b) of Regulation D, raising $131,999,611. The offering was fully subscribed with the first sale occurring on July 21, 2026, and no finders' fees were reported. The biotechnology company, incorporated in …

Aspen Aerogels CEO and CFO to Meet Investors Online Aug. 11

Aspen Aerogels (NYSE: ASPN) announced that its President & CEO, Don Young, and CFO & Treasurer, Grant Thoele, will present at the 29th Annual Oppenheimer Technology, Internet & Communications Conference virtually on August 11, 2026. They will host one-on-one investor meetings and a webcast …

ASP Isotopes projects $14M revenue from PET Labs in 2026

ASP Isotopes Inc. (NASDAQ:ASPI) has outlined significant operational progress across its business units, including projecting $14 million in revenue for its PET Labs division in 2026, up from $6 million in 2025. The company also anticipates commencing helium production at its Renergen subsidiary before …

Jasper Therapeutics, Inc. (JSPR) awards 7,500 stock options to director

Jasper Therapeutics, Inc. (JSPR) director Patrick J. Crutcher was granted 7,500 stock options for Voting Common Stock on July 31, 2026. These options, exercisable at $0.63 per share, will vest in full one year from the grant date, subject to his continued service, and …

ASP Isotopes says PET Labs, Renergen, isotope facilities nearing key milestones (ASPI:NASDAQ)

ASP Isotopes (ASPI) has announced significant operational progress across its business units, as detailed in a recent shareholder letter. The company's PET Labs segment reported over 50% organic revenue growth in the first half of 2026, and its isotope facilities and Renergen projects are …

ASP Isotopes Issues Letter to Shareholders

ASP Isotopes Inc. (ASPI) released a letter to shareholders from its Executive Chairman and CEO, Paul Mann, detailing significant progress across its business units, including over 50% organic revenue growth in PET Labs, anticipated helium production at Renergen, and commercial production nearing for Silicon-28 …

Price to earnings forward of Aspial Corporation Limited – SGX:A30

Jasper Therapeutics (JSPR) grants director option for 7,500 shares

Aspinwall and Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Metaspacex Delays Annual Report Amid Cash Flow Strain and Bond Interest Default

Jasper Therapeutics (NASDAQ: JSPR) outlines 2026 director, auditor and pay votes

Jasper Therapeutics, Inc. (NASDAQ: JSPR) held its 2026 Annual Meeting of Stockholders on July 31, 2026, where shareholders voted on the election of two Class II directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and an advisory vote on …